Jan 12, 2018 - Focus this week was on pipeline updates provided by several companies including Pfizer (PFE) at a healthcare conference while Novo Nordisk's bid to acquire Ablynx also made news.
Jan 11, 2018 - We take a look at the factors that led to the rise in Novo Nordisk's (NVO) share price in the past year.
Jan 10, 2018 - What's Lilly's next stage of growth? CEO Dave Ricks answered this question and more at the J.P. Morgan Healthcare Conference.
Jan 10, 2018 - Novo Nordisk (NVO) announced that Health Canada has approved Ozempic to improve glycemic control in adults with type II diabetes mellitus.
Jan 09, 2018 - Novo Nordisk (NVO) confirmed its revised offer made on Dec 22, to acquire Ablynx NV for $3.1 billion.
Jan 07, 2018 - These new drugs could make billions of dollars for big drugmakers. And they could make you money, too.
Jan 04, 2018 - We take a look at a few Large Cap drug stocks with a favorable combination of Zacks Rank and VGM Score. The stocks are poised to carry on their bull run this year too.
Jan 04, 2018 - Orexigen (OREX) hurt by higher commercialization costs related to Contrave.
Jan 03, 2018 - Merck's (MRK) shares declined in 2017 against an increase witnessed by the large-cap pharma industry. It remains to be seen if the company regains momentum in 2018.
Jan 02, 2018 - Let's take a look at few factors that help in determining if Novo Nordisk (NVO) will be a good investment in 2018.